概括
总体而言,药物过量死亡在2023年略有下降,但涉及兴奋剂过量死亡,特别是可卡因,却有所增加. 老年人和一些人口群体的病率也上升,这凸显了阿片类药物和兴奋剂危机的持续挑战.
科学领域:
- 公共卫生 公共卫生
- 流行病学 流行病学
- 毒理学 毒理学 毒理学
背景情况:
- 药物过量死亡在美国仍然是一个重要的公共卫生问题.
- 了解药物类型和人口群体过量死亡的趋势对于有针对性的干预至关重要.
研究的目的:
- 分析2022年至2023年药物过量死亡率的最新趋势.
- 根据人口特征和特定药物类别,包括阿片类药物和兴奋剂,检查过量死亡的变化.
主要方法:
- 使用国家生命统计系统从2003年到2023年的死亡数据.
- 使用国际疾病分类第10版 (ICD-10) 代码定义药物中毒死亡.
- 使用Joinpoint回归程序计算年龄调整的死亡率和评估趋势.
主要成果:
- 根据年龄调整的药物过量死亡率在2022年至2023年之间从每10万人口中的32.6人降至31.3人.
- 年龄较小的年龄组 (15-54岁) 的发病率下降,但55岁及以上的成年人则增加.
- 涉及合成阿片类药物,海洛因和天然/半合成阿片类药物的死亡人数下降,而涉及可卡因和精神兴奋剂的死亡人数增加.
结论:
- 虽然整体过量死亡率略有下降,但兴奋剂相关死亡率的增加和老年人死亡率的上升标志着不断变化的挑战.
- 需要持续监测和量身定制的公共卫生战略,以应对药物过量流行病的复杂和不断变化的局面.
更多相关视频
09:33Visualizing Field Data Collection Procedures of Exposure and Biomarker Assessments for the Household Air Pollution Intervention Network Trial in India
Published on: December 23, 2022
2.4K
04:04Transauricular Vagus Nerve Stimulation and Electroencephalographic Assessment in Disorders of Consciousness
Published on: July 11, 2025
306
相关概念视频
Clinical Trials: Overview
3.4K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
3.4K
Biostatistics: Overview
379
Biostatistics plays a crucial role in understanding and analyzing data in healthcare and biology. Biostatisticians conduct experiments, gather evidence, and draw meaningful conclusions using statistical methods and techniques. Different variables form the foundation of biostatistical analysis, allowing researchers to understand and interpret data effectively. These variables are classified into different types, each serving a specific purpose in statistical analysis.
Discrete variables are...
Discrete variables are...
379
Data: Types and Distribution
851
In biostatistics, data are the observations collected for analysis. There are two main types: parametric and non-parametric. Parametric data, which include continuous (e.g., weight) and discrete numerical data (e.g., number of tablets), assume a particular distribution pattern, often the normal distribution. Non-parametric data do not adhere to a specific distribution and typically comprise nominal (e.g., gender) and ordinal categorical data (e.g., pain scale ratings).
Distributions in...
Distributions in...
851
Discharge Summary Forms
824
The discharge summary is crucial as it enables a smooth transition from a healthcare facility to a patient's home or another care setting. This critical document facilitates seamless continuity of care, ensuring patients receive the necessary support and attention.
Here's a detailed look at the key components and guidelines for preparing a discharge summary:
Here's a detailed look at the key components and guidelines for preparing a discharge summary:
824
Methods of Documentation V: CBE
987
Charting by Exception, or CBE, is a method of documentation used in healthcare, particularly in nursing, that focuses on documenting only significant or abnormal findings rather than recording every detail. This approach aims to streamline the documentation process, improve efficiency, and ensure that healthcare providers can quickly identify deviations from normalcy in patient assessments.
In CBE, healthcare professionals establish predefined standards of practice that define what constitutes...
In CBE, healthcare professionals establish predefined standards of practice that define what constitutes...
987
SBAR II: Application of SBAR
4.8K
SBAR is an effective communication tool used by healthcare professionals to communicate patient information accurately. SBAR stands for Situation, Background, Assessment, and Recommendation. For a better understanding, an example is given below.
SBAR Report from a Nurse to a Health Care Provider
S: "Hello, Dr. Smith. This is Jane, RN, from the Med Surg unit. I am calling to tell you about Ms. White in Room 210, who is experiencing increased pain and redness at her incision site. Her recent...
SBAR Report from a Nurse to a Health Care Provider
S: "Hello, Dr. Smith. This is Jane, RN, from the Med Surg unit. I am calling to tell you about Ms. White in Room 210, who is experiencing increased pain and redness at her incision site. Her recent...
4.8K
